Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 1998 Mar;43(3):303-10.
doi: 10.1002/ana.410430307.

Hippocampal atrophy and apolipoprotein E genotype are independently associated with Alzheimer's disease

Affiliations
Review

Hippocampal atrophy and apolipoprotein E genotype are independently associated with Alzheimer's disease

C R Jack Jr et al. Ann Neurol. 1998 Mar.

Abstract

A variety of anatomic and functional neuroimaging findings are associated with Alzheimer's disease (AD). One of the strongest imaging associations identified is between AD and hippocampal atrophy. The epsilon4 allele of the apolipoprotein E (ApoE) gene increases the risk of developing AD and lowers the mean age of onset of the disease. The purpose of this study was to assess the association between hippocampal volume and ApoE polymorphisms in elderly control subjects and in patients with probable AD. We performed magnetic resonance imaging-based volume measurements of the hippocampus in 125 cognitively normal elderly controls and 62 patients with probable AD. ApoE genotyping was performed by using standard methods. Hippocampal volumes were significantly smaller in AD cases than in control subjects. Hippocampal volumes did not differ significantly within either clinical group on the basis of ApoE genotype. Both the epsilon4 allele of ApoE and hippocampal atrophy were significantly but independently associated with AD.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Relationships between hippocampal volume, clinical group, and APOE genotype
This four panel collage illustrates a selected imaging slice through the body of the hippocampi in four different subjects. All four were women. The top left panel is a 79-year-old ∈4+ AD patient with normalized hippocampal volumes of 2.26. Top right is a 77-year-old e4− AD patient with normalized hippocampal volumes of 2.42. Bottom left is an 80-year-old ∈4+ control with normalized hippocampal volumes of 4.23. Bottom right is an 80-year-old ∈4− control with normalized hippocampal volumes of 4.36. The right hippocampus is traced as it would be for quantitation in each subject. The figure illustrates significant hippocampal atrophy in AD subjects compared to controls, but no difference in hippocampal volume between ∈4+ and ∈4− members of either clinical group. The hippocampal volumes are normalized by dividing the sum of the right plus left hippocampal volume in mm3 by total intracranial volume in cm3.

Similar articles

Cited by

References

    1. Corder EH, Saunders AM, Strittmatter WJ. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science. 1993;261:921–923. - PubMed
    1. Strittmatter WJ, Saunders AM, Schmechel D, et al. Apolipoprotein E: high acidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer's disease. Proc Natl Acad Sci USA. 1993;90:1977–1981. - PMC - PubMed
    1. Corder EH, Saunders AM, Risch NJ, et al. Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer's disease. Nat Genet. 1994;7:180–184. - PubMed
    1. Kuussisto J, Koivisto K, Kervinen K, et al. Association of apolipoprotein E phenotypes with late onset Alzheimer's disease: population based study. BMJ. 1994;309:636–638. - PMC - PubMed
    1. Mayeux R, Stern Y, Ottman R, et al. The apolipoprotein E4 allele in patients with Alzheimer's disease. Ann Neurol. 1993;34:752–754. - PubMed

Publication types

Substances